Markobenz Ventures Intrinsic Value
Markobenz Ventures (NEWTRAC) median intrinsic value is ₹5.79 from 3 valuation models (range ₹3–₹10), vs current price ₹5.13 — +12.9% upside (Trading Below Median Value), margin of safety 11.4%. Also explore NEWTRAC share price data to track price trends across different timeframes.
NEWTRAC Valuation Methods Summary — DCF, Graham Number & P/E
Markobenz Ventures intrinsic value across 3 models vs current price ₹5.13 — upside/downside and value range per method. For current market price and key ratios, visit NEWTRAC share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹5.79 | ₹5.21 - ₹6.37 | +12.9% | Book Value/Share: ₹5.79, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹10.26 | ₹9.23 - ₹11.29 | +100.0% | Revenue/Share: ₹17.37, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹3.16 | ₹2.84 - ₹3.48 | -38.4% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
NEWTRAC Intrinsic Value vs Market Price — All Valuation Models
Markobenz Ventures fair value range ₹3–₹10 vs current market price ₹5.13 across 3 valuation models. Browse NEWTRAC cash flow statement for revenue, profit, balance sheet and cash flow data.
NEWTRAC Intrinsic Value Analysis — Undervalued or Overvalued?
Markobenz Ventures median intrinsic value ₹5.79, current price ₹5.13 — Trading Below Median Value by 12.9%, margin of safety 11.4%.
What is the intrinsic value of NEWTRAC?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Markobenz Ventures (NEWTRAC) is ₹5.79 (median value). With the current market price of ₹5.13, this represents a +12.9% variance from our estimated fair value.
The valuation range spans from ₹3.16 to ₹10.26, indicating ₹3.16 - ₹10.26.
Is NEWTRAC undervalued or overvalued?
Based on our multi-method analysis, Markobenz Ventures (NEWTRAC) appears to be trading below median value by approximately 12.9%.
NEWTRAC Financial Health — Key Ratios vs Industry Benchmarks
Markobenz Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.22x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NEWTRAC Cash Flow Quality — Operating & Free Cash Flow
Markobenz Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-16 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |